Page last updated: 2024-09-03

ramatroban and cilostazol

ramatroban has been researched along with cilostazol in 1 studies

Compound Research Comparison

Studies
(ramatroban)
Trials
(ramatroban)
Recent Studies (post-2010)
(ramatroban)
Studies
(cilostazol)
Trials
(cilostazol)
Recent Studies (post-2010) (cilostazol)
14210281,508302848

Protein Interaction Comparison

ProteinTaxonomyramatroban (IC50)cilostazol (IC50)
Cytochrome P450 2C9 Homo sapiens (human)10
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)0.4367
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)0.3285

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arima, J; Ayukawa, O; Iguro, Y; Kariyazono, H; Majima, HJ; Masuda, H; Nakamura, K; Onimaru, S; Sakata, R; Yamada, K1

Other Studies

1 other study(ies) available for ramatroban and cilostazol

ArticleYear
Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Diphosphate; Arachidonic Acid; Aspirin; Carbazoles; Cilostazol; Collagen; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclooxygenase Inhibitors; Humans; Microscopy, Confocal; Phosphodiesterase Inhibitors; Plasma; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thromboxane A2, Prostaglandin H2; Reproducibility of Results; Sulfonamides; Tetrazoles

2004
chemdatabank.com